원발 경화 쓸개관염 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "원발 경화 쓸개관염" in Korean language version.

refsWebsite

Global rank Korean rank

4^th place

2^nd place

3^rd place

719^th place

424^th place

doi.org (Global: 2^nd place; Korean: 3^rd place)

Charatcharoenwitthaya P, Lindor KD (2006년 Feb월). “Primary sclerosing cholangitis: diagnosis and management”. 《Current Gastroenterology Reports》 8 (1): 75–82. doi:10.1007/s11894-006-0067-8. PMID 16510038.
Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F (2009년 Sep월). “High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.”. 《Hepatology》 50 (3): 671–3. doi:10.1002/hep.23082. PMC 2758780. PMID 19585548. CS1 관리 - 여러 이름 (링크)

Tischendorf, JJ; Hecker, H; Krüger, M; Manns, MP; Meier, PN (2007년 1월). “Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study”. 《Am J Gastroenterol》 102 (1): 107-14. PMID 17037993. Giving survival time: 306 months

Charatcharoenwitthaya P, Lindor KD (2006년 Feb월). “Primary sclerosing cholangitis: diagnosis and management”. 《Current Gastroenterology Reports》 8 (1): 75–82. doi:10.1007/s11894-006-0067-8. PMID 16510038.
Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F (2009년 Sep월). “High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.”. 《Hepatology》 50 (3): 671–3. doi:10.1002/hep.23082. PMC 2758780. PMID 19585548. CS1 관리 - 여러 이름 (링크)
Tischendorf, JJ; Hecker, H; Krüger, M; Manns, MP; Meier, PN (2007년 1월). “Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study”. 《Am J Gastroenterol》 102 (1): 107-14. PMID 17037993. Giving survival time: 306 months